ACLARION, INC. Other Notes Payable, Current
ACLARION, INC. (ACON) had Other Notes Payable, Current of $0 as of 2024-12-31, per its 10-K filed 2025-04-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherNotesPayableCurrent · last filed 2025-04-09
- 2024-12-31: Other Notes Payable, Current $0.00.
- 2024-09-30: Other Notes Payable, Current $0.00.
- 2024-06-30: Other Notes Payable, Current $777.09K.
- 2024-03-31: Other Notes Payable, Current $670.15K.
| Period end | Other Notes Payable, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-04-09 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $777.09K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $670.15K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.13M 10-K · filed 2025-04-09 |
| 2023-09-30 | $727.54K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $118.84K 10-Q · filed 2023-08-25 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |